InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,626.02
(
0.54%
)
US TECH 100
18,986.40
(
-0.14%
)
Dow Jones
41,393.78
(
0.72%
)
Brent Oil
71.58
(
0.27%
)
Bitcoin
58,587.66
(
-0.99%
)
Post# of 253125
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Bio_pete

Send PM Follow Ignore
Followers 17
Posts 1580
Boards Moderated 0
Alias Born 02/07/2007

Bio_pete

Re: DewDiligence post# 118069

Monday, 04/11/2011 7:28:06 PM

Monday, April 11, 2011 7:28:06 PM

Post# of 253125
"The 23% and 36% reductions in relapse rate and disability progression, respectively, are in line with what Teva has been hinting at for the past few months. "

How do these rates compare to Copaxone?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up